288 related articles for article (PubMed ID: 2718699)
21. Thyroid-associated ophthalmopathy in black South African patients with Graves' disease: relationship to antiflavoprotein antibodies.
Joffe B; Gunji K; Panz V; Zouvanis M; Swanson J; Ackrell BA; Wall JR
Thyroid; 1998 Nov; 8(11):1023-7. PubMed ID: 9848717
[TBL] [Abstract][Full Text] [Related]
22. Antibody-dependent cell-mediated cytotoxicity against orbital target cells in thyroid-associated ophthalmopathy and related disorders; close relationship between serum cytotoxic antibodies and parameters of eye muscle dysfunction.
Barsouk A; Peele KA; Kiljanski J; Stolarski C; Nebes V; Kennerdell JS; Volpe R; Wall JR
J Endocrinol Invest; 1996 Jun; 19(6):334-41. PubMed ID: 8844451
[TBL] [Abstract][Full Text] [Related]
23. The differential diagnostic problems in unilateral euthyroid Graves' ophthalmopathy.
Perrild H; Feldt-Rasmussen U; Bech K; Ahlgren P; Hansen JM
Acta Endocrinol (Copenh); 1984 Aug; 106(4):471-6. PubMed ID: 6548073
[TBL] [Abstract][Full Text] [Related]
24. Suppressed natural killer cell activity in patients with euthyroid Graves' ophthalmopathy.
Pedersen BK; Perrild H; Feldt-Rasmussen U; Christensen T; Klarlund K; Hansen JM
Autoimmunity; 1989; 2(4):291-8. PubMed ID: 2491612
[TBL] [Abstract][Full Text] [Related]
25. Childhood Graves' ophthalmopathy: results of a European questionnaire study.
Krassas GE; Segni M; Wiersinga WM
Eur J Endocrinol; 2005 Oct; 153(4):515-21. PubMed ID: 16189172
[TBL] [Abstract][Full Text] [Related]
26. Graves' ophthalmopathy: natural history and treatment outcomes.
Noth D; Gebauer M; Müller B; Bürgi U; Diem P
Swiss Med Wkly; 2001 Oct; 131(41-42):603-9. PubMed ID: 11820071
[TBL] [Abstract][Full Text] [Related]
27. Clinical features of Graves' ophthalmopathy in an incidence cohort.
Bartley GB; Fatourechi V; Kadrmas EF; Jacobsen SJ; Ilstrup DM; Garrity JA; Gorman CA
Am J Ophthalmol; 1996 Mar; 121(3):284-90. PubMed ID: 8597271
[TBL] [Abstract][Full Text] [Related]
28. Smoking and risk of Graves' disease.
Prummel MF; Wiersinga WM
JAMA; 1993 Jan; 269(4):479-82. PubMed ID: 8419666
[TBL] [Abstract][Full Text] [Related]
29. Graves' ophthalmopathy in relation to cigarette smoking and ethnic origin.
Tellez M; Cooper J; Edmonds C
Clin Endocrinol (Oxf); 1992 Mar; 36(3):291-4. PubMed ID: 1563082
[TBL] [Abstract][Full Text] [Related]
30. Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology.
Villanueva R; Inzerillo AM; Tomer Y; Barbesino G; Meltzer M; Concepcion ES; Greenberg DA; MacLaren N; Sun ZS; Zhang DM; Tucci S; Davies TF
Thyroid; 2000 Sep; 10(9):791-8. PubMed ID: 11041456
[TBL] [Abstract][Full Text] [Related]
31. Serum IL-18 levels are not increased in patients with untreated Graves' ophthalmopathy.
Wakelkamp IM; Prummel MF; Wiersinga WM
Horm Metab Res; 2004 Jan; 36(1):44-7. PubMed ID: 14983406
[TBL] [Abstract][Full Text] [Related]
32. Pretibial myxedema without ophthalmopathy: an initial presentation of Graves' disease.
Lohiya S; Lohiya V; Stahl EJ
Am J Med Sci; 2013 Jul; 346(1):73-5. PubMed ID: 23514670
[TBL] [Abstract][Full Text] [Related]
33. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].
Chen W; Man N; Li YS; Shan ZY; Teng WP
Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113
[TBL] [Abstract][Full Text] [Related]
34. Ophthalmic Graves' disease.
Mornex R; Fournier G; Berthezene F
Mod Probl Ophthalmol; 1975; 14():426-31. PubMed ID: 1242209
[TBL] [Abstract][Full Text] [Related]
35. Age and stress as determinants of the severity of hyperthyroidism caused by Graves' disease in newly diagnosed patients.
Vos XG; Smit N; Endert E; Brosschot JF; Tijssen JG; Wiersinga WM
Eur J Endocrinol; 2009 Feb; 160(2):193-9. PubMed ID: 18974230
[TBL] [Abstract][Full Text] [Related]
36. Relationship between Graves' ophthalmopathy and type of treatment of Graves' hyperthyroidism.
Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Pinchera A
Thyroid; 1992; 2(2):171-8. PubMed ID: 1525588
[TBL] [Abstract][Full Text] [Related]
37. Thyrotropin receptor antibodies in hypothyroid Graves' disease.
Kasagi K; Hidaka A; Nakamura H; Takeuchi R; Misaki T; Iida Y; Konishi J
J Clin Endocrinol Metab; 1993 Feb; 76(2):504-8. PubMed ID: 8094394
[TBL] [Abstract][Full Text] [Related]
38. Thyroid antibody-negative euthyroid Graves' ophthalmopathy.
Tabasum A; Khan I; Taylor P; Das G; Okosieme OE
Endocrinol Diabetes Metab Case Rep; 2016; 2016():160008. PubMed ID: 27284451
[TBL] [Abstract][Full Text] [Related]
39. The influence of prior hyperthyroidism on euthyroid graves' ophthalmopathy.
Termote K; Decallonne B; Mombaerts I
J Ophthalmol; 2014; 2014():426898. PubMed ID: 25045529
[TBL] [Abstract][Full Text] [Related]
40. Graves' ophthalmopathy.
Wall JR; Henderson J; Strakosch CR; Joyner DM
Can Med Assoc J; 1981 Apr; 124(7):855-62, 866. PubMed ID: 7011529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
